Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

506 results

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Withdrawn applications Remove Withdrawn applications filter Direct healthcare professional communication Remove Direct healthcare professional communication filter

Medicine type Biosimilar Remove Biosimilar filter Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter

Sort by

List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Mylan

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 01/04/2020, , Revision: 3, Authorised, Last updated: 13/05/2022
List item

Human medicine European public assessment report (EPAR): Atazanavir Krka

atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019, , Revision: 1, Authorised, Last updated: 09/12/2021
List item

Human medicine European public assessment report (EPAR): Atazanavir Mylan

atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016, , Revision: 12, Authorised, Last updated: 26/09/2022
List item

Human medicine European public assessment report (EPAR): Atosiban SUN

atosiban (as acetate), Premature Birth
Date of authorisation: 31/07/2013, , Revision: 9, Authorised, Last updated: 09/02/2022
List item

Human medicine European public assessment report (EPAR): Aybintio

bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020, , , Revision: 6, Authorised, Last updated: 15/12/2022
List item

Human medicine European public assessment report (EPAR): Azacitidine Accord

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 13/02/2020, , Revision: 5, Authorised, Last updated: 19/07/2022
List item

Human medicine European public assessment report (EPAR): Azacitidine betapharm

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 24/03/2020, , Revision: 4, Authorised, Last updated: 10/06/2022
List item

Human medicine European public assessment report (EPAR): Azacitidine Mylan

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 27/03/2020, , Revision: 4, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Bemfola

follitropin alfa, Anovulation
Date of authorisation: 26/03/2014, , Revision: 10, Authorised, Last updated: 19/12/2022
List item

Human medicine European public assessment report (EPAR): Benepali (updated)

etanercept, Arthritis, Psoriatic; Arthritis, Rheumatoid; Psoriasis
Date of authorisation: 13/01/2016, , Revision: 18, Authorised, Last updated: 06/01/2023
List item

Human medicine European public assessment report (EPAR): Binocrit

epoetin alfa, Anemia; Kidney Failure, Chronic
Date of authorisation: 28/08/2007, , Revision: 20, Authorised, Last updated: 31/10/2019
List item

Human medicine European public assessment report (EPAR): Biograstim

filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 15/09/2008, , Revision: 8, Withdrawn, Last updated: 19/01/2017
List item

Human medicine European public assessment report (EPAR): Blitzima

rituximab, Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017, , Revision: 17, Authorised, Last updated: 30/11/2022
List item

Veterinary medicine European public assessment report (EPAR): Bluevac BTV (previously known as Bluevac BTV8)

bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated], Sheep; Cattle
Date of authorisation: 14/04/2011, , Revision: 7, Authorised, Last updated: 27/10/2020
List item

Human medicine European public assessment report (EPAR): Bortezomib Accord

bortezomib, Multiple Myeloma
Date of authorisation: 20/07/2015, , Revision: 13, Authorised, Last updated: 25/03/2022
List item

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi

bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019, , Revision: 5, Authorised, Last updated: 01/09/2021
List item

Human medicine European public assessment report (EPAR): Bortezomib Hospira

bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016, , Revision: 12, Authorised, Last updated: 01/03/2022
List item

Human medicine European public assessment report (EPAR): Bortezomib Sun

bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016, , Revision: 12, Authorised, Last updated: 09/09/2021
List item

Human medicine European public assessment report (EPAR): Brineura

cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017, , , , , Revision: 6, Authorised, Last updated: 16/08/2022
List item

Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi

busulfan, Hematopoietic Stem Cell Transplantation
Date of authorisation: 22/09/2014, , Revision: 9, Authorised, Last updated: 18/05/2021
List item

Human medicine European public assessment report (EPAR): Bylvay

Odevixibat, Cholestasis, Intrahepatic
Date of authorisation: 16/07/2021, , , , Revision: 2, Authorised, Last updated: 05/10/2022
List item

Human medicine European public assessment report (EPAR): Byooviz (updated)

ranibizumab, Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Myopia, Degenerative
Date of authorisation: 18/08/2021, , , Revision: 5, Authorised, Last updated: 05/01/2023
List item

Human medicine European public assessment report (EPAR): Cabazitaxel Accord (updated)

cabazitaxel, Prostatic Neoplasms, Castration-Resistant
Date of authorisation: 28/08/2020, , Revision: 3, Authorised, Last updated: 16/01/2023
List item

Human medicine European public assessment report (EPAR): Cabometyx

cabozantinib (s)-malate, Carcinoma, Renal Cell; Carcinomas, Hepatocellular
Date of authorisation: 09/09/2016, , Revision: 15, Authorised, Last updated: 05/12/2022
List item

Human medicine European public assessment report (EPAR): Capecitabine Accord

capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012, , Revision: 16, Authorised, Last updated: 10/12/2021